Evaluating a collagen supplement for joint function improvement
Randomized, Double-blind Clinical Study to Evaluate the Effect of a Food Supplement Based on Hydrolyzed Collagen on Joint Function in a Moderately Active Population.
NA · Universidad Católica San Antonio de Murcia · NCT05917925
This study is testing whether a collagen supplement can help people with knee pain feel better and improve their joint function while being moderately active.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Universidad Católica San Antonio de Murcia (other) |
| Locations | 1 site (La Ñora, Murcia) |
| Trial ID | NCT05917925 on ClinicalTrials.gov |
What this trial studies
This clinical study assesses the impact of a hydrolyzed collagen-based supplement on pain, function, and quality of life in individuals who are moderately physically active and experience knee pain. The study employs a randomized, double-blind, placebo-controlled design with two parallel groups, where participants will receive either the collagen supplement or a placebo for a duration of 12 weeks. The primary focus is on alleviating exercise-associated knee pain and enhancing overall joint function.
Who should consider this trial
Good fit: Ideal candidates are individuals who exercise regularly and have experienced persistent knee pain for at least two months.
Not a fit: Patients with severe illnesses, chronic inflammatory diseases, or those currently using joint health supplements may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve joint function and quality of life for individuals suffering from knee pain.
How similar studies have performed: Other studies have shown promising results with collagen supplementation for joint health, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals who exercise regularly and meet the WHO definition of being moderately active. * Persistent exercise-associated knee pain lasting at least 2 months prior to study inclusion. * Knee pain score on the visual analogue pain scale of at least 30 mm, taking into account that the scale has a maximum range of 100 mm. Exclusion Criteria: * Individuals with severe illness. * Subjects who are taking or have been treated within the last 7 days with glucosamine, chondroitin sulphate, collagen or hyaluronic acid injections or any dietary supplement indicated for joint health. * Subjects with chronic inflammatory diseases affecting the musculoskeletal apparatus. * Subjects with obesity (BMI ≥ 30 Kg/m2). * Allergy or known hypersensitivity to any of the ingredients in the investigational product. * Phenylketonuria. * Treatment with narcotics, steroidal anti-inflammatory drugs or immunosuppressants. - Symptoms of extreme pain requiring high doses of analgesic therapy for a period of time longer than 2 weeks or intra-articular injection treatment. * Individuals with diabetes. * Pregnant women. * Lactating women. * Subjects who are participating in a clinical trial. * Subjects who have participated in a clinical trial for pain in the last month.
Where this trial is running
La Ñora, Murcia
- Research Center for High Performance Sport. Catholic University of Murcia — La Ñora, Murcia, Spain (RECRUITING)
Study contacts
- Study coordinator: Francisco Javier Martínez Noguera, PhD
- Email: fjmartinez3@ucam.edu
- Phone: 968278566
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pain, Acute, Pain, Chronic, Knee Osteoarthritis, Knee Injuries, Hydrolyzed collagen, Post-exercise pain, Supplementation, Inflammation